Initial studies have suggested that dietary carnitine stimulates the breakdown of fats into energy, reduces the amount of lactic acid produced during exercise, and speeds up recovery from exercise stress
Observational studies reporting vitamin D and micronutrient insufficiencies during prolonged GLP-1RA use [94, 95, 101] suggest that nutritional monitoring may be warranted, although the magnitude and causal pathways remain to be clarified
On April 1, the FDA approved Foundayo (orforglipron), Eli Lillys once-daily oral GLP-1 receptor agonist for obesity, which is the first oral GLP-1 approved for weight management and the fastest new molecular entity approval since 2002
The answer depends entirely on the concentration of your specific formulation
This unique NSAID-antagonizing effect presents a significant potential clinical application for patients requiring long-term NSAID therapy